Join to View Full Profile
4850 Union AveSan Jose, CA 95124
Phone+1 408-559-5600
Fax+1 408-559-5320
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Neal Slatkin, MD is a board certified neurologist in San Jose, California. He is currently licensed to practice medicine in California and Pennsylvania.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1982 - 1984
Virginia Commonwealth University Health SystemResidency, Neurology, 1979 - 1981
NYU Grossman School of MedicineResidency, Neurology, 1978 - 1979
NYU Grossman School of MedicineResidency, Physical Medicine and Rehabilitation, 1977 - 1978
NYU Grossman School of MedicineInternship, Transitional Year, 1976 - 1977
Certifications & Licensure
CA State Medical License 1984 - 2028
PA State Medical License 1984 - 1988
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsReductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.Lynn R Webster, Darren Brenner, Robert J Israel, Nancy Stambler, Neal E Slatkin
Pain Medicine. 2023-03-01 - 1 citationsImpact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.Neel Mehta, Neal E Slatkin, Robert J Israel, Nancy Stambler, Eric D Shah
Journal of Pain Research. 2023-01-01 - Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.David Farchadi, Neal E Slatkin, Nancy Stambler, Robert J Israel, Michael Matus
Current Therapeutic Research, Clinical and Experimental. 2023-01-01









